PF-044467943
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-044467943, covering 2020-11-19 to 2020-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease [Phase 1]